Agenus Inc. (AGEN) Social Stream



Agenus Inc. (AGEN): $15.46

0.54 (-3.37%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

C

Add AGEN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#76 of 354

in industry

AGENUS INC (AGEN) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering AGEN.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 4 $11 $7 $9 $0.715 1158.74%
2021-12-16 4 $12 $7 $10 $0.715 1298.6%
2022-03-01 4 $12.001 $7 $10 $0.715 1298.6%
2022-04-13 4 $14 $7 $9.666 $0.715 1251.89%
2022-05-11 3 $8 $7 $7.5 $0.715 948.95%
2022-08-09 3 $8 $8 $8 $0.715 1018.88%
2022-11-14 4 $8 $5 $6.333 $0.715 785.73%
2023-02-07 5 $8.3 $5 $6.825 $0.715 854.55%
2023-02-28 6 $8.3 $5 $7.06 $0.715 887.41%
2023-06-05 7 $8.3 $5 $7.06 $0.715 887.41%
2023-07-03 8 $8.3 $5 $7.216 $0.715 909.23%
2023-08-09 6 $8.3 $6 $7.66 $0.715 971.33%
2023-10-23 6 $8.301 $6 $7.66 $0.715 971.33%
2023-11-09 5 $8 $6 $6.5 $0.715 809.09%

The Trend in the Analyst Price Target


Over the past 48 weeks, AGEN's average price target has gone down $0.33.

AGEN reports an average of 474.55% for its upside potential over the past 39 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-06-05 8 8.300 5 7.06 1.730 308.09%
2023-08-14 6 8.301 6 7.66 1.340 471.64%
2023-10-23 6 8.301 6 7.66 0.875 775.43%
2023-11-09 5 8.301 6 6.86 0.753 811.02%
2023-11-09 5 8.000 6 6.50 0.753 763.21%

AGEN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


Over the past 52 weeks, AGEN's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AGEN as an investment opportunity.

  • AGEN has a higher upside potential (average analyst target price relative to current price) than 2036.62% of all US stocks.
  • AGENUS INC's average analyst price target is greater than 161.09% of all US stocks.
  • AGENUS INC's variance in analysts' estimates is lower than -430.19% of Pharmaceutical Products stocks.
  • AGENUS INC's number of analysts covering the stock is greater than 569.11% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AGENUS INC are ACOR, AIM, and MBOT.

Is AGEN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!